Seres Therapeutics
MCRB
MCRB
85 hedge funds and large institutions have $326M invested in Seres Therapeutics in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.16% more ownership
Funds ownership: 3.8% → 3.96% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
34% less capital invested
Capital invested by funds: $494M → $326M (-$168M)
Holders
85
Holding in Top 10
1
Calls
$1.07M
Puts
$698K
Top Buyers
| 1 | +$7.43M | |
| 2 | +$7.27M | |
| 3 | +$3.02M | |
| 4 |
Jennison Associates
New York
|
+$2.31M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.57M |
Top Sellers
| 1 | -$4.12M | |
| 2 | -$3.29M | |
| 3 | -$2.54M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.17M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.71M |